Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
IFNAR2 is a type I transmembrane protein and a subunit of the heterodimeric receptor for type I interferons. It plays a crucial role in initiating cellular responses to viral infections and modulating the immune system. Upon binding type I interferons, IFNAR2, along with IFNAR1, activates the JAK-STAT signaling pathway, leading to the expression of interferon-stimulated genes (ISGs).
Agonism (via interferon binding leading to receptor activation and downstream signaling)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interferon alpha/beta receptor subunit 2 (IFNAR2).